Because many successful targeted anti-cancer therapies have relied heavily on the use of predictive biomarkers [166], more investigation into this area is crucial for determining the most effective application of IGF/IGF-1R inhibitors as a lung cancer therapy. The gene discussed is IGF1; the disease is lung cancer.